• Sainath N. Ingole
• Pogulwad Kalyani Kailas

The insulin pump, also known as continuous subcutaneous insulin, has developed in acceptance and sophistication as a flexible, near-physiologic programmable insulin delivery technology. The use of glucose sensor continuous monitoring offers unparalleled prediction and access to a patient's blood glucose levels. Actions are being taken. To combine the two technologies, moving from "sensordriven" and "sensor-augmented" pumps to autonomous, fully automated system for detecting and delivering objects. pumps that are implanted and an Additionally, early-phase "bionic pancreas" are actively being developed. "Pancreas replacement" is refined. It looks to be among the numerous options providing hope for those with diabetes. Endocrinologists and diabetic specialists will always have knowledge in this area, but it is advisable for primary care physicians to possess a functional understanding of insulin pumps and sensors. Insulin pump guarantee the best possible clinical treatment and patient decision-making

insulin pump, glucose, diabetes mellitus

"INSULIN PUMP THERAPY FOR THE MANAGEMENT OF DIABETES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 11, page no.g268-g285, November-2024, Available :http://www.jetir.org/papers/JETIR2411624.pdf

"INSULIN PUMP THERAPY FOR THE MANAGEMENT OF DIABETES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 11, page no. ppg268-g285, November-2024, Available at : http://www.jetir.org/papers/JETIR2411624.pdf